EUVIMEDEUVIMED entdecken
Kohortenstudie

Clinical characteristics of persistent ısotretinoin-associated ınflammatory back pain: a retrospective cohort study

Fatih Albayrak, Orhan Zengin, Reha Baran, Mehmet Şakir Altuner, Osman Cüre, Ayşe Nur Bayındır, Özlem Kudaş, Rabia Sağır, Ozlem Dogan Agbuga, Lütfi Akyol, Menice Güler Şen, Mehmet Ali Balcı und 20 weitere

Clinical Rheumatology · 2026-12 · 45 (12) · 7391-7399

DOI: 10.1007/s10067-026-08486-0 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 23.10.2026. Verfasst von Fatih Albayrak und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye. drfalbayrak@yahoo.com. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Back Pain, Dermatologic Agents. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Isotretinoin is commonly used to treat severe acne vulgaris, and reports of inflammatory back pain (IBP) during therapy have grown over the past decade. Previous studies have reported improvement in musculoskeletal symptoms following isotretinoin discontinuation; however, persistent symptoms have also been described. This study aimed to describe the clinical and demographic characteristics of isotretinoin-associated IBP according to symptom persistence after isotretinoin discontinuation.

Methods

This retrospective cohort study included 100 consecutive adults with new-onset IBP fulfilling ASAS criteria during isotretinoin therapy. Clinical, laboratory, and imaging data were collected. Patients were classified as persistent or non-persistent according to whether IBP continued beyond three months after isotretinoin discontinuation.

Results

The median age was 24 years, and 80% of patients were women. IBP developed at a median of 2 months after isotretinoin initiation. Magnetic resonance imaging (MRI) showed bilateral sacroiliitis in 72% of patients, unilateral sacroiliitis in 20%, and normal findings in 8%. HLA-B27 positivity was uncommon (3/78). After isotretinoin discontinuation, 23 patients had persistent IBP and 77 had non-persistent IBP. Patients with persistent IBP had higher post-discontinuation BASDAI scores (median 5.05 vs. 2.00; p < 0.001), less BASDAI improvement (0.00 vs. 3.70; p < 0.001), more frequent Achilles enthesopathy (39.1% vs. 14.3%; p = 0.016), and more frequent sulfasalazine use (30.4% vs. 3.8%; p < 0.001).

Conclusion

Isotretinoin-associated IBP had a generally favorable course, with symptom improvement in most patients during follow-up, although symptoms persisted beyond three months in nearly one-quarter. Achilles enthesopathy at presentation was more frequent among patients with persistent IBP, suggesting that careful rheumatological follow-up may be particularly important in this subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinAcne VulgarisBack PainDermatologic AgentsSacroiliitisHumansFemaleRetrospective StudiesAdultYoung AdultMaleMagnetic Resonance ImagingAdolescent

Stichwörter der Autor:innen

EnthesopathyInflammatory back painIsotretinoinSacroiliitisSpondyloarthropathy

Substanzen

IsotretinoinDermatologic Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye. drfalbayrak@yahoo.com.
  • Department of Rheumatology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.
  • Department of Rheumatology, Bursa Çekirge State Hospital, Bursa, Türkiye.
  • Department of Rheumatology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Türkiye.
  • Department of Rheumatology, Denizli State Hospital, Denizli, Türkiye.
  • Department of Rheumatology, Gaziosmanpaşa Training and Research Hospital, Istanbul, Türkiye.

Zitieren

APA

Albayrak, F., Zengin, O., Baran, R., Altuner, M. Ş., Cüre, O., Bayındır, A. N., Kudaş, Ö., Sağır, R., Agbuga, O. D., Akyol, L., Şen, M. G., Balcı, M. A., Tezcan, D., Koç, E., Zontul, S., Ulutaş, F., Öz, B., Karaca, A. D., Yıldırım, A., …, & Kısacık, B. (2026). Clinical characteristics of persistent ısotretinoin-associated ınflammatory back pain: a retrospective cohort study. Clinical Rheumatology, 45(12), 7391-7399. https://doi.org/10.1007/s10067-026-08486-0

Vancouver

Albayrak F, Zengin O, Baran R, Altuner MŞ, Cüre O, Bayındır AN, et al. Clinical characteristics of persistent ısotretinoin-associated ınflammatory back pain: a retrospective cohort study. Clinical Rheumatology. 2026;45(12):7391-7399. doi:10.1007/s10067-026-08486-0

BibTeX
@article{Albayrak2026,
  author = {Albayrak, Fatih and Zengin, Orhan and Baran, Reha and Altuner, Mehmet Şakir and Cüre, Osman and Bayındır, Ayşe Nur and Kudaş, Özlem and Sağır, Rabia and Agbuga, Ozlem Dogan and Akyol, Lütfi and Şen, Menice Güler and Balcı, Mehmet Ali and Tezcan, Dilek and Koç, Emrah and Zontul, Sezgin and Ulutaş, Firdevs and Öz, Burak and Karaca, Aylin Dolu and Yıldırım, Alper and Mengi, Alperen and Kızıltepe, Melih and Kılıç, Özlem and Mısırcı, Salim and Ök, Zeynep Dündar and Kökoğlu, Emel Oğuz and İbramkhalilova, İrada and Demirci, Mehmet Gürdal and Yavuz, Nurcihan Savaş and Karataş, Ahmet and Oner, Fatma Alibaz and Koca, Süleyman Serdar and Kısacık, Bünyamin},
  title = {Clinical characteristics of persistent ısotretinoin-associated ınflammatory back pain: a retrospective cohort study},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {12},
  pages = {7391--7399},
  doi = {10.1007/s10067-026-08486-0}
}
Kostenlos starten →